Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology
Ann Surg Oncol
.
2015 Dec;22 Suppl 3(Suppl 3):S1604.
doi: 10.1245/s10434-014-4340-z.
Authors
Cristina R Ferrone
1
,
David T Ting
2
,
Mohammad Shahid
3
4
,
Ioannis T Konstantinidis
3
,
Francesco Sabbatino
3
,
Lipika Goyal
2
,
Travis Rice-Stitt
4
,
Aysha Mubeen
3
,
Kshitij Arora
3
4
,
Nabeel Bardeesey
2
,
John Miura
5
,
T Clark Gamblin
5
,
Andrew X Zhu
2
,
Darrell Borger
3
,
Keith D Lillemoe
3
,
Miguel N Rivera
4
,
Vikram Deshpande
6
Affiliations
1
Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
[email protected]
.
2
Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
3
Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
4
Division of Pathology, Massachusetts General Hospital, Boston, MA, USA.
5
Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, USA.
6
Division of Pathology, Massachusetts General Hospital, Boston, MA, USA.
[email protected]
.
PMID:
25575648
PMCID:
PMC5286909
DOI:
10.1245/s10434-014-4340-z
No abstract available
Publication types
Published Erratum
Grants and funding
K12 CA087723/CA/NCI NIH HHS/United States